Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults
Claudia Tandler, Jonas S. Heitmann, Tanja Michel, et al.
International Journal of Infectious Diseases (2023) Vol. 139, pp. 69-77
Open Access | Times Cited: 9

Showing 9 citing articles:

Pan‐Variant SARS‐CoV‐2 Vaccines Induce Protective Immunity by Targeting Conserved Epitopes
Masaud Shah, Sung Ung Moon, Ji‐Yon Shin, et al.
Advanced Science (2025)
Open Access
Multi-disciplinary approaches paving the way for clinically effective peptide vaccines for cancer
Bansari A. Shah, James A. Holden, Jason C. Lenzo, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
Integrating Machine Learning-Enhanced Immunopeptidomics and SARS-CoV-2 Population-Scale Analyses Unveils Novel Antigenic Features for Next-Generation COVID-19 Vaccines
Étienne Caron, Kevin A. Kovalchik, David Hamelin, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 2
iVAC-XS15-CLL01: personalized multi-peptide vaccination in combination with the TLR1/2 ligand XS15 in CLL patients undergoing BTK-inhibitor-based regimens
Alexander Englisch, Clara Hayn, Susanne Jung, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Machine learning-enhanced immunopeptidomics applied to T-cell epitope discovery for COVID-19 vaccines
Kevin A. Kovalchik, David Hamelin, Peter Kubiniok, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
An Adjuvanted Vaccine-Induced Pathogenesis Following Influenza Virus Infection
Shiou‐Chih Hsu, Kun‐Hsien Lin, Yung-Chieh Tseng, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 569-569
Open Access
AML-VAC-XS15-01: protocol of a first-in-human clinical trial to evaluate the safety, tolerability and preliminary efficacy of a multi-peptide vaccine based on leukemia stem cell antigens in acute myeloid leukemia patients
Susanne Jung, Annika Nelde, Yacine Maringer, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Special Issue: “Vaccination and Global Health”
Shaodi Ma, Qian Bi, Li Liu, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1223-1223
Open Access
Warehouse-based, immunopeptidome-guided design of personalised peptide vaccines shows feasibility in clinical trial evaluation in CLL patients
Jonas S. Heitmann, Susanne Jung, Marcel Wacker, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Page 1

Scroll to top